Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDLIM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMMSON - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DNAJC19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PICALM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927760 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIPPLY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT79 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927865 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SEC61A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CANX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on